Related Experiment Video
Updated: May 9, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
[Vacuum-assisted closure in a patient with methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis after
Akihiko Yamauchi1, Makoto Hashimoto
1Department of Cardiovascular Surgery, Tomishiro Central Hospital, Tomishiro, Japan.
Abstract:
Mediastinitis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious complication in cardio-thoracic surgery. In mediastinitis cases, acute thoracic aortic graft infection is a lethal status. We described a successful treatment of MRSA thoracic graft infection by V.A.C. ATS therapy. Ascending aortic graft replacement was performed in a 55-year-old man, and deep mediastinitis by MRSA occurred on postoperative day 6. On postoperative day 8, negative pressure wound therapy (NPWT) using a home-made system, was carried out after re-sternotomy, debridement of inflammatory tissues and irrigation. Following the 1st NPWT, V.A.C. ATS therapy was introduced. MRSA vanished from the mediastinum after V.A.C. ATS therapy, and the mediastinum was closed with the omentum. He was discharged 43 days after the 1st operation. We consider that the advantage of V.A.C. ATS therapy is "making a bed-side free status" in even mediastinitis patients, which enables active walking and reinforcement of physical strength. V.A.C. ATS therapy might be useful for the treatment of MRSA mediastinitis.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis after thoracic surgery can be life-threatening. Negative pressure wound therapy, specifically V.A.C. ATS, offers a successful treatment approach for MRSA thoracic graft infections.
Area of Science:
- Cardiothoracic Surgery
- Infectious Diseases
- Wound Healing
Background:
- Mediastinitis, particularly graft infection by methicillin-resistant Staphylococcus aureus (MRSA), poses a severe risk following cardio-thoracic surgery.
- Acute thoracic aortic graft infection represents a critical and often lethal complication.
Observation:
- A case study involving a 55-year-old male patient who developed deep mediastinitis caused by MRSA six days post-ascending aortic graft replacement.
- Initial treatment included re-sternotomy, debridement, irrigation, and a home-made negative pressure wound therapy (NPWT) system.
- Subsequently, V.A.C. Advanced Tissue Regeneration (ATS) therapy was implemented.
Findings:
- V.A.C. ATS therapy led to the eradication of MRSA from the mediastinum.
- The mediastinum was successfully closed using omentum.
- The patient was discharged 43 days after the initial surgery, indicating a positive treatment outcome.
Implications:
- V.A.C. ATS therapy may provide a significant advantage by allowing patients, even those with mediastinitis, greater mobility and improved physical strength.
- This therapy shows potential as an effective treatment for MRSA mediastinitis, improving patient recovery and quality of life.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care
Mitral Stenosis III: Medical Management
Mechanism of Antibiotic Resistance in MRSA
Cardiopulmonary Resuscitation II: ACLS Airway Management
